Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy?

HPB

Volumn 11, Issue 6, 2009, Pages 459-464

  Senzolo, Marco ^a   Sartori, Maria Teresa ^a   Lisman, Ton ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Liver cirrhosis; Thrombosis

Indexed keywords

ACENOCOUMAROL; ALBUMIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN;

ALBUMIN BLOOD LEVEL; ANTICOAGULANT THERAPY; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; DRUG CONTRAINDICATION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LUNG EMBOLISM; PORTAL VEIN THROMBOSIS; REVIEW; RISK FACTOR; THROMBOELASTOGRAPHY; THROMBOSIS; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

EID: 70349557597     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2009.00079.x     Document Type: Review

References (33)

1. Lisman T, Leebeek FW, de Groot PG. (2002) Haemostatic abnormalities in patients with liver disease. J Hepatol 37:280-287.
2. Senzolo M, Burra P, Cholongitas E, Burroughs AK. (2006) New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol 12:7725-7736.
3. Rapaport SI. (2000) Coagulation problems in liver disease. Blood Coagul Fibrinolysis 11 (Suppl. 1):S69-S74.
4. Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M et al. (2005) Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 41:553-558.
5. Senzolo M, Burroughs AK. (2007) Hemostasis alterations in liver disease and liver transplantation. In: Kitchens G, Alving B, Kessler G, eds. Consultative Hemostasis and Thrombosis. Philadelphia, PA: Saunders, pp. 490, 502.
6. Northup PG. (2009) Hypercoagulation in liver disease. Clin Liver Dis 13:109-116.
7. Fimognari FL, Violi F. (2008) Portal vein thrombosis in liver cirrhosis. Intern Emerg Med 3:213-218.
8. Denninger MH, Chait Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A et al. (2000) Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31:587-591.
9. Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Sacco M, Martino R et al. (2002) Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy 34:535-538.
10. Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G. (1995) Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology 21:1238-1247.
11. Wanless IR, Liu JJ, Butany J. (1995) Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology 21:1232-1237.
12. Budhiraja R, Tuder RM, Hassoun PM. (2004) Endothelial dysfunction in pulmonary hypertension. Circulation 109:159-165.
13. Northup PG, McMahon MM, Ruhl AP, Altschuler SE, Volk-Bednarz A, Caldwell SH et al. (2006) Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol 101:1524-1528.
14. Tripodi A, Primignani M, Chantarangkul V, Clerici M, Dell'era A, Fabris F et al. (2006) Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology 44:440-445.
15. Tripodi A, Primignani M, Chantarangkul V, Viscardi Y, Dell'era A, Fabris FM et al. (2009) The coagulopathy of cirrhosis assessed by thromboelastometry and its correlation with conventional coagulation parameters. Thromb Res 124:132-136.
16. Tripodi A, Chantarangkul V, Primignani M, Fabris F, Dell'era A, Sei C et al. (2007) The international normalized ratio calibrated for cirrhosis (INR-(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation. Hepatology 46:520-527.
17. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ et al. (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160:809-815.
18. Huerta C, Johansson S, Wallander MA, Garcia Rodriguez LA. (2007) Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med 167:935-943.
19. Sogaard KK, Horvath-Puho E, Gronbaek H, Jepsen P, Vilstrup H, Sorensen HT. (2009) Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol 104:96-101.
20. Gulley D, Teal E, Suvannasankha A, Chalasani N, Liangpunsakul S. (2008) Deep vein thrombosis and pulmonary embolism in cirrhosis patients. Dig Dis Sci 53:3012-3017.
21. Garcia-Fuster MJ, Abdilla N, Fabia MJ, Fernandez C, Oliver V, Forner MJ. (2008) [Venous thromboembolism and liver cirrhosis]. Rev Esp Enferm Dig 100:259-262.
22. Webster GJ, Burroughs AK, Riordan SM. (2005) Review article: portal vein thrombosis - new insights into aetiology and management. Aliment Pharmacol Ther 21:1-9.
23. Ben Ari Z, Panagou M, Patch D, Bates S, Osman E, Pasi J et al. (1997) Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol 26:554-559.
24. Segal H, Cottam S, Potter D, Hunt BJ. (1997) Coagulation and fibrinolysis in primary biliary cirrhosis compared with other liver disease and during orthotopic liver transplantation. Hepatology 25:683-688.
25. Pihusch R, Rank A, Gohring P, Pihusch M, Hiller E, Beuers U. (2002) Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease. J Hepatol 37:548-555.
26. Nieuwdorp M, Stroes ES, Meijers JC, Buller H. (2005) Hypercoagulability in the metabolic syndrome. Curr Opin Pharmacol 5:155-159.
27. Yudkin JS, Juhan-Vague I, Hawe E, Humphries SE, di MG, Margaglione M et al. (2004) Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism 53:852-857.
28. Samonakis DN, Koutroubakis IE, Sfiridaki A, Malliaraki N, Antoniou P, Romanos J et al. (2004) Hypercoagulable states in patients with hepatocellular carcinoma. Dig Dis Sci 49:854-858.
29. Cerutti E, Stratta C, Romagnoli R, Schellino MM, Skurzak S, Rizzetto M et al. (2004) Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation. Liver Transpl 10:289-294.
30. Tsuji K, Eguchi Y, Kodama M. (1996) Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection. J Am Coll Surg 183:230-238.
31. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR et al. (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133 (6 Suppl.):381S-453S.
32. Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B et al. (2005) Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 54:691-697.
33. Senzolo M, Ferronato C, Burra P, Sartori MT. (2009) Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered. Intern Emerg Med 4:161-162; author reply, 163-164.